Stocks · Health care · Pharmaceutical Preparations

Tango Therapeutics, Inc.

TNGX Clue Score51
United States Fiscal year ends December CIK 0001819133 Results filed 11 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Mace Rothenberg
18 Nov 2024
Director
Buy
10,000
$3.78
$37.80K
Mace Rothenberg
14 Nov 2024
Director
Buy
10,000
$3.62
$36.20K
Boxer Capital, LLC
16 Oct 2023
See remarks
Buy
500,000
$6.84
$3.42M
Boxer Capital, LLC
13 Oct 2023
See remarks
Buy
750,000
$7.07
$5.30M
Boxer Capital, LLC
11 Aug 2023
See remarks
Buy indirect
475,000
$5.15
$2.45M
Boxer Capital, LLC
13 Oct 2022
10% owner
Buy
70,000
$4.65
$325.23K
Boxer Capital, LLC
12 Oct 2022
10% owner
Buy
50,000
$4.43
$221.64K
Boxer Capital, LLC
11 Oct 2022
10% owner
Buy
117,000
$4.25
$497.71K
Boxer Capital, LLC
6 Oct 2022
10% owner
Buy
70,394
$4.06
$286.07K
Boxer Capital, LLC
5 Oct 2022
10% owner
Buy
40,500
$3.84
$155.41K
Boxer Capital, LLC
5 Oct 2022
10% owner
Buy
45,500
$3.93
$178.64K
Boxer Capital, LLC
4 Oct 2022
10% owner
Buy
25,606
$3.67
$93.98K
BCTG Holdings, LLC
8 Sep 2020
10% owner
Buy
533,500
$10.00
$5.34M

What was left out

Form 4 filings counted 115
Amendments (4/A) skipped 2
Filings about a different issuer 1
Unreadable filings 0
Joint filings 29
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 16
Sales at will 66
Transactions with no price 0
Shares from compensation/vesting 1,572,962
Sales filed before the plan box existed 2
History held since 10 Sep 2020